BLPH

Bellerophon Therapeutics, Inc.

Delisted

BLPH was delisted on the 13th of October, 2023.

17 hedge funds and large institutions have $68.4M invested in Bellerophon Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
17
Holders Change
+17
Holders Change %
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
17
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SBK
1
Steven B. Klinsky
$44.6M 4,859,885 +4,859,885 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$12M 1,302,070 +1,302,070 New
SIG
3
Senator Investment Group
New York
$4.12M 448,679 +448,679 New
BBA
4
Baker Bros. Advisors
New York
$3.21M 350,000 +350,000 New
HCMT
5
Highland Capital Management (Texas)
Texas
$1.49M 162,177 +162,177 New
CCA
6
Catalyst Capital Advisors
New York
$1.06M 115,000 +115,000 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$864K 94,131 +94,131 New
SM
8
Sabby Management
Florida
$275K 30,000 +30,000 New
Morgan Stanley
9
Morgan Stanley
New York
$194K 21,137 +21,137 New
Goldman Sachs
10
Goldman Sachs
New York
$159K 17,290 +17,290 New
Millennium Management
11
Millennium Management
New York
$142K 15,427 +15,427 New
BG
12
BlackRock Group
United Kingdom
$133K 14,528 +14,528 New
BIT
13
BlackRock Institutional Trust
California
$125K 13,566 +13,566 New
UBS Group
14
UBS Group
Switzerland
$13K 1,456 +1,456 New
BIM
15
BlackRock Investment Management
Delaware
$8K 846 +846 New
BA
16
BlackRock Advisors
Delaware
$3K 318 +318 New
TRCT
17
Tower Research Capital (TRC)
New York
$3K 332 +332 New